Vivodyne
When Vivodyne, one of University of Pennsylvania’s successful Bioengineering startups was ready to expand, PurePM was engaged as the owner’s representative on their new project.
Menu
PurePM is managing a new $286M Drug Safety Testing Facility for MilliporeSigma, a subsidiary of Merck KGaA, Darmstadt, Germany. The facility reflects the growing demand for biosafety testing in pharmaceutical production and development. As the owner’s representative, PurePM is managing all aspects of the project, from preparing budgets and schedules, supervising scope and design, overseeing construction, handling owner FF&E selection, and organizing move-in activities. PurePM will work closely with the management team on campus to maintain existing operations as the construction work is ongoing.
Once complete, the 250,000 SF facility will perform biosafety contract testing for traditional and novel therapies. The facility will also house analytical development, viral clearance sites, and cell bank manufacturing services. The construction and operations of the facility will create more than 500 jobs in Rockville, MD.
When Vivodyne, one of University of Pennsylvania’s successful Bioengineering startups was ready to expand, PurePM was engaged as the owner’s representative on their new project.
Integral Molecular is one of the founding members of Philadelphia’s biotech community, with over 20 years of experience in the industry.
Invisible Sentinel, a BioMérieux company, expanded their facility into a new home within the Philadelphia Navy Yard.
As part of their continued expansion in 2017 Hackensack Meridian acquired a portion of the Old Roche Pharmaceuticals site on Nutley New Jersey. The site was well suited for their goals of expanding research and growing.
Begin with the end in mind.